LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969 | +10.0% | 245,342 | -12.9% | 0.00% | +100.0% |
| Q2 2023 | $881 | +6.4% | 281,574 | +54.1% | 0.00% | 0.0% |
| Q1 2023 | $828 | -12.4% | 182,742 | -20.1% | 0.00% | 0.0% |
| Q4 2022 | $945 | -99.9% | 228,774 | -22.8% | 0.00% | 0.0% |
| Q3 2022 | $948,000 | +175.6% | 296,367 | +68.8% | 0.00% | – |
| Q2 2022 | $344,000 | -50.9% | 175,542 | +1.6% | 0.00% | -100.0% |
| Q1 2022 | $700,000 | -66.3% | 172,742 | -10.4% | 0.00% | -66.7% |
| Q4 2021 | $2,080,000 | -26.8% | 192,774 | -21.7% | 0.00% | -25.0% |
| Q3 2021 | $2,840,000 | +47.7% | 246,274 | +25.8% | 0.00% | +100.0% |
| Q2 2021 | $1,923,000 | -38.0% | 195,774 | -7.9% | 0.00% | -50.0% |
| Q1 2021 | $3,104,000 | -34.5% | 212,474 | -4.0% | 0.00% | -20.0% |
| Q4 2020 | $4,740,000 | +57.0% | 221,374 | +11.2% | 0.01% | +66.7% |
| Q3 2020 | $3,020,000 | +12.7% | 199,074 | -4.6% | 0.00% | +50.0% |
| Q2 2020 | $2,680,000 | – | 208,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |